Prenatal karyotyping was undertaken in 569 consecutive amniotic fluid samples where the indication for amniocentesis was two sequential raised maternal serum alpha-fetoprotein concentrations. In 475 successful cultures five chromosome abnormalities were found-four constitutional anomalies (47,XXY; 47,XYY; an inherited inv(8) (p23qll); and a de-novo translocation t(6;7) (pll;p22)) and a culture-derived anomaly (trisomy 2) found in amniotic fluid cells but not in the fetus aborted because it had spina bifida. Of the pregnancies complicated by constitutional abnormalities, only the pregnancy in which the de-novo translocation was detected was terminated. No chromosome abnormalities were detected in the 17 pregnancies which miscarried after amniocentesis.
Introduction
The advent of wide-scale maternal serum ax-fetoprotein (AFP) screening programmes has generated a new category of amniocentesis samples. Such samples are procured primarily with the objective of confirming or excluding a fetal neural-tube defect by the technically easy AFP1 and acetylcholinesterase assays.2 The question whether fetal karyotype analysis should also be carried out remains open. Since as many as 20% of all preg-nancies may be subjected to amniocentesis because of raised maternal serum AFP concentrations,3 the more complex process of chromosome analysis would throw a considerable load on antenatal diagnostic services. The principal justification for karyotyping these samples is the possibility that chromosomal abnormalities causing congenital malformations or mental retardation occur more often in mothers with raised serum AFP concentrations than in an unselected population. We review the results of karyotype analysis in a series of amniotic fluid samples where the indication for amniocentesis was two sequential high maternal AFP values.
Patients and methods
The patients studied were all those on whom amniocentesis was performed between January 1976 and December 1979 because of high maternal serum AFP values. Women whose risk of fetal abnormality justified amniocentesis whatever the serum AFP value were excluded. Those with two sequential AFP concentrations above the 95th percentile of the normal range were referred for further clinical investigations and possible ultrasound scanning.3 A total of 570 patients who showed no clinical signs of threatened abortion, whose gestational age was confirmed by ultrasonic investigations of biparietal diameter, and who appeared not to have a twin pregnancy were referred for amniocentesis. One The low overall success rate (83%) for the amniotic fluid cell cultures was worrying. Apart from the blood contamination and samples with very low viable cell counts, an additional factor affecting the success rate was the quality of fetal bovine serum.9 During one phase of our survey unsatisfactory batches of fetal calf serum were encountered. Although these haC proved adequate in their growthpromoting ability for established amniotic fluid cell cultures, they proved to be disastrous for the initial stages of cellular adhesion. As a result several cultures failed. Viable cell counts were useful in pinpointing cases where problems were likely to occur and required only 0 1 ml of fluid. Studies for rapidly adhering cells, which helped in the differential diagnosis of fetal defects, used only 0 5 ml of fluid, so that removing 0-6 ml of fluid from an average volume of almost 13 ml of liquor was very unlikely to have contributed to the culture failures. As the indication for amniocentesis in these pregnancies was a high maternal serum AFP concentration (risk of neural-tube defect) we did not request repeat tap for chromosome studies if the culture failed.
Chromosome abnormalities were detected in five amniotic fluid samples (table I) . Both fetuses with sex chromosome aneuploidy (47,XXY and 47,XYY) proceeded to term. Male infants of normal birth weight were delivered and the karyotypes confirmed from cord blood cultures. Also allowed to proceed to term was a pregnancy in which a pericentric inversion of chromosome 8 was detected, 46,XY, inv(8) (p23ql 1). Chromosome studies of parental blood showed that the mother also had inv (8) . Our unit cytogenetic registry contains five pedigrees (including two which are very extensive) of inv (8) with identical breakpoints. The inversion chromosome in all pedigrees appeared to have normal familial transmission and was not associated with any abnormalities or increased risk of fetal loss. A normal male infant was delivered and the karyotype confirmed. In one amniotic fluid sample an apparently balanced translocation between chromosomes 6 and 7 was detected. Neither parent carried the translocation (full testing of markers was carried out for paternity), and so this was a de-novo rearrangement. The risk for people carrying de-novo translocations was ascertained by studies in the unit registry and found to be about one in six for mental retardation; no specific congenital abnormalities were implicated. The parents requested termination of pregnancy because of the chance of mental retardation: a phenotypically normal fetus was aborted. The presence of the 46,XX, t(6;7) (pll;p22) translocation karyotype was confirmed in all the fetal tissues studied-blood, lung, kidney, thymus, adrenal, ovary, skin, and muscle.
In the only case of autosomal aneuploidy an extra chromosome 2 was detected in the cultured amniotic fluid cells. Nevertheless, the amniotic fluid AFP concentration was grossly raised, an acetylcholinesterase band was seen on gel electrophoresis, and rapidly adhering cells suggested a fetus with a neural-tube defect. The consultant obstetricians in both cases of sex chromosome abnormality in our study decided not to tell the parents, and the pregnancies continued.
Of the 570 mothers subjected to amniocentesis, 17 (30%) We are grateful to Dr J B Scrimgeour and Professor H J Evans for instigating this project, and to the consultant obstetricians who supplied the samples. We also thank the nursing and records staff in each hospital and our technicians for their help.
